Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors
G Veerman, V W Ruiz van Haperen, J B Vermorken, et al.
British Journal of Cancer
|
June 12, 2003
Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines
A M Bergman, H M Pinedo, I Talianidis, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell lines
C J van Moorsel, G Veerman, V W Ruiz van Haperen, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Mechanisms of synergism between gemcitabine and cisplatin
C J van Moorsel, G Veerman, J B Vermorken, et al.
Biochemical Pharmacology
|
May 2, 2001
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines
A M Bergman, B Munch-Petersen, P B Jensen, et al.
Cancer Research
|
August 1, 1994
Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
V W Ruiz van Haperen, G Veerman, S Eriksson, et al.
Biochemical Pharmacology
|
February 5, 1999
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines
C J van Moorsel, H M Pinedo, G Veerman, et al.
Biochemical Pharmacology
|
February 5, 1999
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase
A M Bergman, H M Pinedo, A P Jongsma, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits
K Smid, A M Bergman, P P Eijk, et al.
Biochimica Et Biophysica Acta
|
March 4, 2000
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines
C J van Moorsel, A M Bergman, G Veerman, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors
G Veerman, V W Ruiz van Haperen, J B Vermorken, et al.
British Journal of Cancer
|
June 12, 2003
Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines
A M Bergman, H M Pinedo, I Talianidis, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell lines
C J van Moorsel, G Veerman, V W Ruiz van Haperen, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Mechanisms of synergism between gemcitabine and cisplatin
C J van Moorsel, G Veerman, J B Vermorken, et al.
Biochemical Pharmacology
|
May 2, 2001
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines
A M Bergman, B Munch-Petersen, P B Jensen, et al.
Cancer Research
|
August 1, 1994
Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
V W Ruiz van Haperen, G Veerman, S Eriksson, et al.
Biochemical Pharmacology
|
February 5, 1999
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines
C J van Moorsel, H M Pinedo, G Veerman, et al.
Biochemical Pharmacology
|
February 5, 1999
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase
A M Bergman, H M Pinedo, A P Jongsma, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits
K Smid, A M Bergman, P P Eijk, et al.
Biochimica Et Biophysica Acta
|
March 4, 2000
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines
C J van Moorsel, A M Bergman, G Veerman, et al.
Page
of 4